Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitetaurx.com
Twitter@TauRx
CategoryBioTech
Employees
Founded2002

Offices

Singapore, SGP
3, Shenton Way, #21-04
Shenton House
Singapore, 068805, SGP

People

Board of Directors
Director
Director
Director
Director
Director
Global Project Lead, Phase 3, TRx-237-007 (Aberdeen)
Global Project Lead, Phase 3, TRx-237-015 (Aberdeen)
Show All People

Funding

TOTAL $42M
FUNDING TOTAL $42M
Venture Round, 11/2012
Genting management
$31.5M
Private Equity, 3/2013
$10.5M

Tags

TauRx Pharmaceuticals

TauRx Therapeutics Ltd was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases based on an entirely new approach which targets aggregates of abnormal fibres of Tau protein that form inside nerve cells in the brain. The TauRx team have since discovered that LMTX™ could also have beneficial effects in several other neurodegenerative diseases associated with Tau pathology, as well as other protein aggregation disorders including Parkinson’s, Huntington’s and Frontotemporal Dementia (Pick’s Disease). While TauRx headquarters are in Singapore, its primary research facilities are in Aberdeen, Scotland.

Recent Milestones

Videos

Screenshots

TauRx Pharmaceuticals screenshot
Above: TauRx Pharmaceuticals
Uploaded: 11/21/12

Sources

  1. TauRx Receives US$31.5 million equity investment genting unit (bernama.com) [edit]
  2. TauRx Pharmaceuticals Receives USD10.5M Equity Investment from Dundee Corporation (finsmes.com) [edit]
Edit This Page
Last Edited 4/7/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy